Outcomes of intrasheath steriod injection for treatment of de quervains tenosynovitis
International Journal of Development Research
Outcomes of intrasheath steriod injection for treatment of de quervains tenosynovitis
Received 25th November, 2018; Received in revised form 03rd December, 2018; Accepted 03rd January, 2019; Published online 27th February, 2019
Copyright © 2019, Rohan Memon and Nirav Patel. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction: De Quervain's tenosynovitis is a stenosing tenosynovitis of the first dorsal compartment of the wrist. Various modalities of treatment include splinting, local corticosteroid injection and surgical decompression. In this prospective study the effectiveness of local corticosteroid injections for de Quervain's tenosynovitis was assessed. Materials and methodology: Fourty five patients were included in the study. All patients included in this study showed no improvement with oral analgesics. Pain and tenderness was recorded as per the VAS scale before the procedure. A mixture of 1 ml (10mg) of triamcinolone acetonide and 1 ml of 1% lidocaine hydrochloride was injected in first dorsal compartment of involved wrist. Patients were followed up every monthly for 6 months and assessment was done for reduction of pain and tenderness by measuring the VAS score and doing Finkelstiens test. Results: Out of Fourty five patients 23 patinets had improvement in symptoms and negative filkensteins test at the end of two months. The remaining 22 patients were again given steroid injection at the end of 2 months and 18 patients showed complete relief of symptoms and had negative filkensteins test. Remaining 4 patients did not show any clinical improvement and were taken for surgical release. Conclusion: We conclude that one or two local steroid injections in the first dorsal compartment leads to significant improvement in patients with de Quervain's tenosynovitis.